Research Article
Noninvasive Encapsulated Follicular Variant of Papillary Thyroid Cancer: Clinical Lessons from a Community-Based Endocrine Surgical Practice
Table 1
Demographics, US, surgery and pathology results in 37 noninvasive EFVPTC patients.
| Patient | Gender | Age | EFVPTC size (cm) | Echo type | Cytology | Afirma GEC | Operation | Nodes | Other cancer |
| | F | 34 | 6.1 | Iso | FN/SFN | | TT | 0/1 | No | 2 | M | 52 | 5.6 | Hetero | Benign | | LHT, RHT | 0/1 | No | 3 | F | 31 | 4.7 | Iso | Benign | | TT | | MicroPTC-c | 4 | F | 69 | 6.9 | Hypo | FN/SFN | Benign | TT | 0/0 | No | 5 | F | 36 | 4.5 | Hypo | | | TT | 0/0 | MicroPTC-c | | F | 27 | 4.2 | Hetero | FLUS/AUS | | LHT | 0/1 | No | 7 | F | 55 | 5.8 | Iso | | | LHT | 0/0 | No | 8 | M | 30 | 4.1 | Iso | FLUS/AUS | Suspicious | RHT | 0/0 | No | 9 | F | 51 | 3.9 | Hetero | FLUS/AUS | Suspicious | TT | 0/1 | MicroFvPTC | 10 | M | 56 | 3.6 | Hetero | FLUS/AUS | Suspicious | LHT | 0/3 | MicroPTC | 11 | F | 41 | 4.4 | Iso | FN/SFN | Suspicious | RHT | 0/0 | No | 12 | F | 50 | 3.1 | Iso | | | LHT | 0/2 | No | 13 | F | 38 | 3.8 | Iso | | | LHT | 0/1 | No | 14 | F | 30 | 2.8 | Iso | FN/SFN | | LHT | 0/1 | No | 15 | F | 35 | 2.6 | Hetero | Benign | | TT | 0/1 | No | 16 | F | 21 | 3.15 | Hetero | FN/SFN | | RHT | 0/1 | No | 17 | F | 50 | 2.4 | Hypo | Benign | | TT | 0/3 | MicroPTC | 18 | F | 60 | 3 | Iso | FLUS/AUS | Suspicious | TT | 0/0 | MicroFvPTC | 19 | F | 46 | 1.4 | Hypo | FLUS/AUS | Suspicious | RHT | 0/1 | No | 20 | M | 38 | 3 | Iso | FLUS/AUS | Suspicious | TT | 0/2 | MicroPTC | 21 | F | 32 | 3.3 | Iso | FN/SFN | Suspicious | TT | 0/0 | No | 22 | M | 53 | 2.5 | Iso | FN/SFN | | RHT | 0/0 | No | 23 | F | 16 | 2.7 | Iso | Benign | | LHT, RHT | 0/1 | MicroFvPTC-c | 24 | F | 37 | 2.63 | Hypo | FLUS/AUS | | TT | 0/3 | No | 25 | F | 53 | 1.9 | Hypo | | | LHT, RHT | 0/1 | 2.1 cm FVPTC and microFVPTC-c | 26 | F | 56 | 2.53 | Hetero | Benign | | RHT, LHT | 0/1 | MicroPTC | 27 | F | 55 | 1.6 | Hypo | FLUS/AUS | | TT | 0/1 | No | 28 | M | 39 | 2.1 | Iso | FLUS/AUS | Suspicious | LHT | 0/1 | No | 29 | F | 40 | 1.3 | Hypo | FLUS/AUS | Suspicious | TT | 0/0 | No | 30 | M | 64 | 1.6 | Hypo | Benign | | TT | 0/0 | No | 31 | F | 58 | 1.3 | Iso | FLUS/AUS | Suspicious | LHT | 0/1 | MicroPTCs | 32 | F | 55 | 1.1 | Iso | FLUS/AUS | Suspicious | TT | 0/0 | No | 33 | F | 37 | 0.8 | Iso | | | TT | 0/4 | No | | F | 37 | 1.3 | Iso | | | TT + CND | | 1.5 cm PTC-c | 35 | F | 45 | 0.9 | Iso | FLUS/AUS | Suspicious | TT | 0/0 | 2 cm FvPTC | 36 | F | 32 | 4 | Iso | FN/SFN | | TT | 0/0 | No | 37 | M | 56 | 4.3 | Iso | Benign | | TT | 0/0 | No |
|
|
Patient treated with radioiodine, PAX8/PPAR gamma translocation, NRAS mutation, nodal micrometastases, and -c contralateral lobe from encapsulated EFVPTC tumor.
|